Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2886)
All Articles published online
|
Dec 14, 2007 (publication date) through Apr 19, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Amarapurkar DN. Telbivudine: A new treatment for chronic hepatitis B. World J Gastroenterol 2007; 13(46): 6150-6155 [PMID: 18069753 DOI: 10.3748/wjg.v13.i46.6150] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v13/i46/6150.htm |
| Number | Citing Articles |
| 1 |
Jia‐Horng Kao, Tarik Asselah, Xiao‐Guang Dou, Kamal Hamed. Telbivudine therapy for chronic hepatitis B: A journey to identify super‐responders and to optimize treatment using the roadmap model. Journal of Gastroenterology and Hepatology 2017; 32(1): 73 doi: 10.1111/jgh.13512
|
| 2 |
J. Liu, T. Chen, Y. Zhao. Telbivudine therapy for gravidas with chronic hepatitis B infection and patients at risk of renal impairment. Journal of Viral Hepatitis 2017; 24(S1): 6 doi: 10.1111/jvh.12787
|
| 3 |
Erik O. Soley, Zachary J. Devereaux, L.A. Hamlow, G. Berden, J. Oomens, M.T. Rodgers. IRMPD action spectroscopy, ER-CID experiments, and theoretical approaches investigate intrinsic L-thymidine properties compared to D-thymidine: Findings support robust methodology. International Journal of Mass Spectrometry 2019; 441: 32 doi: 10.1016/j.ijms.2019.04.003
|
| 4 |
Reena Singh, Seema Gupta, Pradeep Kumar. The Role of Nanotechnology in Antiviral Regime: An Overview. Nano LIFE 2022; 12(01) doi: 10.1142/S1793984421300119
|
| 5 |
Milena Georgieva, Charilaos Xenodochidis, Natalia Krasteva. Old age as a risk factor for liver diseases: Modern therapeutic approaches. Experimental Gerontology 2023; 184: 112334 doi: 10.1016/j.exger.2023.112334
|
| 6 |
Li-fen Han, Jian-ming Zheng, Li-qing Zheng, Hai-bing Gao, Li-xia Chen, Qing-ling Xu, Yi-hong Chai, Xin Zhang, Chen Pan, Lv-feng Yao. Telbivudine can safely reduce mother-to-child transmission in chronic hepatitis B women after 12 weeks of gestation. BMC Infectious Diseases 2019; 19(1) doi: 10.1186/s12879-019-4250-6
|
| 7 |
Wattana Leowattana, Tawithep Leowattana. Chronic hepatitis B: New potential therapeutic drugs target. World Journal of Virology 2022; 11(1): 57-72 doi: 10.5501/wjv.v11.i1.57
|
| 8 |
Annapoorna Vadlamani, K. Ravindhranath, B. Sreenivasa Rao. Detection and Quantification of Two Potential Genotoxic Impurities in Telbivudine Active
Pharmaceutical Ingredient by Targeted Ultra Performance LC-MS/MS Analysis. Asian Journal of Chemistry 2022; 34(12): 3383 doi: 10.14233/ajchem.2022.26905
|
| 9 |
Jinxin Zheng, Minggui Deng, Xiaoliang Qiu, Zhong Chen, Duoyun Li, Xiangbin Deng, Qiwen Deng, Zhijian Yu. Rhabdomyolysis, lactic acidosis, and multiple organ failure during telbivudine treatment for hepatitis B: a case report and review of the literature. Journal of Medical Case Reports 2017; 11(1) doi: 10.1186/s13256-017-1498-6
|
| 10 |
Florina-Daniela Cojocaru, Doru Botezat, Ioannis Gardikiotis, Cristina-Mariana Uritu, Gianina Dodi, Laura Trandafir, Ciprian Rezus, Elena Rezus, Bogdan-Ionel Tamba, Cosmin-Teodor Mihai. Nanomaterials Designed for Antiviral Drug Delivery Transport across Biological Barriers. Pharmaceutics 2020; 12(2): 171 doi: 10.3390/pharmaceutics12020171
|
| 11 |
Yarden Ariav, James H Ch’ng, Heather R. Christofk, Noga Ron-Harel, Ayelet Erez. Targeting nucleotide metabolism as the nexus of viral infections, cancer, and the immune response. Science Advances 2021; 7(21) doi: 10.1126/sciadv.abg6165
|